Skip to main content
Identification of MAFB/MAF-dependent soluble factors from macrophages as novel prognostic biomarkers for severity and progression of COVID-19
Analysis of the role of SARS CoV 2 specific antibodies in driving antibody-dependent NK and cross-talk between the interferon and NF-?B pathways in COVID
Inflammation viral determinants in the cytokine storm within COVID- 19
Endoplasmic reticulum stress/unfolded protein response a critical trigger of cytokine storm in CoVid-19 disease
Searching for new therapeutic targets to prevent lung microvascular endothelial barrier disruption and pulmonary edema caused by SARS-CoV2-induced cytokine storm
Caracterizacion de la respuesta inmunologica al virus SARS- CoV-2 para el control de la fase epidemica.
Inhibidores del inflamasoma contra el si?ndrome de liberacio?n de citoquinas en COVID-19
Development of COVID19 targeted therapeutic and diagnostic tools DeCOV-DT
Nano particulas inmunosupresoras con tropismo a pulmon para frenar la tormenta de citoquinas causante de la inmunopatologia pulmonar y la replicacion viral
COVID-19: anti-infectious and anti-inflammatory action of immunomodulatory parasite molecules in a safe-to-use synthetic format